Bright Minds Biosciences ...
(DRUG)
undefined
undefined%
At close: undefined
41.45
0.61%
After-hours Dec 13, 2024, 04:16 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | 72.45K | 6.04K | - | - | - |
Gross Profit | -72.45K | -6.04K | - | - | - |
Operating Income | -7.21M | -14.74M | -8.76M | -469.36K | -78.72K |
Interest Income | - | - | - | - | - |
Pretax Income | -7.37M | -14.96M | -8.65M | -480.38K | -78.72K |
Net Income | -7.37M | -15.19M | -8.52M | -485.94K | -78.72K |
Selling & General & Admin | 2.21M | 2.55M | 2.29M | 114.51K | 36.71K |
Research & Development | 5.00M | 12.18M | 6.31M | 354.85K | 42.01K |
Other Expenses | - | -243.08K | -181.74K | -5.45K | - |
Operating Expenses | 7.21M | 14.73M | 8.60M | 469.36K | 78.72K |
Interest Expense | 19.75K | 222.78K | - | - | - |
Selling & Marketing Expenses | 119.42K | 551.86K | 852.15K | 9.62K | 36.60K |
Cost & Expenses | 7.21M | 14.73M | 8.60M | 469.36K | 78.72K |
Income Tax | - | 222.78K | -135.43K | 5.57K | -236.15 |
Shares Outstanding (Basic) | 3.72M | 2.47M | 1.79M | 1.28M | 1.28M |
Shares Outstanding (Diluted) | 3.72M | 2.47M | 1.79M | 1.28M | 1.28M |
EPS (Basic) | -1.98 | -6.15 | -4.74 | -0.38 | -0.06 |
EPS (Diluted) | -1.98 | -6.15 | -4.74 | -0.38 | -0.06 |
EBITDA | -7.28M | -14.96M | - | - | - |
Depreciation & Amortization | 72.45K | 6.04K | 8.62M | 474.93K | 236.15K |